Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Epidemiology of cardiovascular disease in China: current features and implicationsNature reviews cardiology, 2019-04, Vol.16 (4), p.203-212 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2019 ;ISSN: 1759-5002 ;EISSN: 1759-5010 ;DOI: 10.1038/s41569-018-0119-4 ;PMID: 30467329Full text available |
|
2 |
Material Type: Article
|
2021 ESC Guidelines on cardiovascular disease prevention in clinical practiceEuropean journal of preventive cardiology, 2022-02, Vol.29 (1), p.5 [Peer Reviewed Journal]ISSN: 2047-4881 ;EISSN: 2047-4881 ;DOI: 10.1093/eurjpc/zwab154 ;PMID: 34558602Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular HealthCurrent nutrition reports, 2018-12, Vol.7 (4), p.198-206 [Peer Reviewed Journal]The Author(s) 2018 ;EISSN: 2161-3311 ;DOI: 10.1007/s13668-018-0248-8 ;PMID: 30264354Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesThe New England journal of medicine, 2023-12, Vol.389 (24), p.2221-2232 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2307563 ;PMID: 37952131Full text available |
|
5 |
Material Type: Article
|
Vitamin D Supplements and Prevention of Cancer and Cardiovascular DiseaseThe New England journal of medicine, 2019-01, Vol.380 (1), p.33-44 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1809944 ;PMID: 30415629Full text available |
|
6 |
Material Type: Article
|
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and CancerThe New England journal of medicine, 2019-01, Vol.380 (1), p.23-32 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1811403 ;PMID: 30415637Full text available |
|
7 |
Material Type: Article
|
Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesThe New England journal of medicine, 2017-08, Vol.377 (7), p.644-657 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1611925 ;PMID: 28605608Full text available |
|
8 |
Material Type: Article
|
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 DiabetesThe New England journal of medicine, 2017-09, Vol.377 (13), p.1228-1239 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1612917 ;PMID: 28910237Full text available |
|
9 |
Material Type: Article
|
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesThe New England journal of medicine, 2019-01, Vol.380 (4), p.347-357 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1812389 ;PMID: 30415602Full text available |
|
10 |
Material Type: Article
|
Sitting Time, Physical Activity, and Risk of Mortality in AdultsJournal of the American College of Cardiology, 2019-04, Vol.73 (16), p.2062-2072 [Peer Reviewed Journal]2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019. The Authors ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.02.031 ;PMID: 31023430Full text available |
|
11 |
Material Type: Article
|
Effects of n−3 Fatty Acid Supplements in Diabetes MellitusThe New England journal of medicine, 2018-10, Vol.379 (16), p.1540-1550 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1804989 ;PMID: 30146932Full text available |
|
12 |
Material Type: Article
|
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesThe New England journal of medicine, 2015-11, Vol.373 (22), p.2117-2128 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1504720 ;PMID: 26378978Full text available |
|
13 |
Material Type: Article
|
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME TrialDiabetes care, 2018-02, Vol.41 (2), p.356-363 [Peer Reviewed Journal]2017 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-1096 ;PMID: 29203583Full text available |
|
14 |
Material Type: Article
|
Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction: An Individual Participant Meta-Analysis of Prospective Observational Data From 17,635 SubjectsJournal of the American College of Cardiology, 2014-02, Vol.63 (7), p.636-646 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Feb 25, 2014 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.09.063 ;PMID: 24239664 ;CODEN: JACCDIFull text available |
|
15 |
Material Type: Article
|
CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countriesCardiovascular diabetology, 2021-07, Vol.20 (1), p.154-154, Article 154 [Peer Reviewed Journal]2021. The Author(s). ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2021 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-021-01344-0 ;PMID: 34315481Full text available |
|
16 |
Material Type: Article
|
Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-upDiabetes care, 2016-05, Vol.39 (5), p.686-693 [Peer Reviewed Journal]2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association May 2016 ;2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. 2016 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc15-1990 ;PMID: 26861924 ;CODEN: DICAD2Full text available |
|
17 |
Material Type: Article
|
Polypill Strategy in Secondary Cardiovascular PreventionThe New England journal of medicine, 2022-09, Vol.387 (11), p.967-977 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2208275 ;PMID: 36018037Full text available |
|
18 |
Material Type: Article
|
Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-upThe New England journal of medicine, 2019-06, Vol.380 (23), p.2215-2224 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1806802 ;PMID: 31167051Full text available |
|
19 |
Material Type: Article
|
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 DiabetesThe New England journal of medicine, 2013-07, Vol.369 (2), p.145-154 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1212914 ;PMID: 23796131 ;CODEN: NEJMAGFull text available |
|
20 |
Material Type: Article
|
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational studyDiabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.3442017 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.13077 ;PMID: 28771923Digital Resources/Online E-Resources |